<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.0 20040830//EN" "http://dtd.nlm.nih.gov/publishing/2.0/journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" dtd-version="2.0" xml:lang="EN">

  <front>

    <journal-meta>

      <journal-title>International Journal of Pharmacology</journal-title>

      <issn pub-type="ppub">1811-7775</issn>

      <issn pub-type="epub">1812-5700</issn>

      <publisher>

        <publisher-name>Asian Network for Scientific Information</publisher-name>

      </publisher>

    </journal-meta>


    <article-meta>

      <article-id pub-id-type="doi">10.3923/ijp.2017.773.784</article-id>


      <title-group>

        <article-title><![CDATA[Drug Discovery Processes to Drug Targeting Mechanisms]]></article-title>

      </title-group>


      <contrib-group>

        <contrib contrib-type="author" xlink:type="simple">


          <name name-style="western">

            <surname>Maqbool</surname>

            <given-names>Faheem</given-names>

          </name>


          <name name-style="western">

            <surname>Abid</surname>

            <given-names>Amman</given-names>

          </name>


          <name name-style="western">

            <surname>Ahmed</surname>

            <given-names>Ishtiaq</given-names>

          </name>


        </contrib>

      </contrib-group>


      <pub-date pub-type="collection">


        <month>7</month>




        <year>2017</year>

      </pub-date>


      <volume>13</volume>

      <issue>7</issue>


      <abstract><![CDATA[<p>Drug discovery in different time frames provides a reflection in the struggle of scientists to generate synthetic products from a natural source. The complex processes exist in the development of the new drug from novel ideas. The duration may vary 10-15 year with estimation cost of $1.5 billion. The stratification of different assays involved in development phase leads to the acceptability of drug molecule. In the discovery phase, implementation of powerful techniques such as combinatorial chemistry and molecular modeling has also participated in the identification of drug target molecules. The advancement in molecular biology especially genomic science has also imparted a profound role in the discovery phase. However, with bioinformatics branch, it allows us to derive more suitable points for attacking the drug molecule in different disease conditions. However, the review will describe the preclinical stages, identification and validation of target through HTS (high throughput screening assay) and finally approval of drug molecule for further clinical development.</p>]]></abstract>


    </article-meta>

  </front>


  <ref-list>




      <ref id="1764227">

        <label>1</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Maqbool, F., H. Bahadar and M. Abdollahi,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2014</year>

          <article-title><![CDATA[Science for the benefits of all: The way from idea to product.]]></article-title>

          <source>J. Med. Hypotheses Ideas,</source>

          <volume>8</volume>

          <fpage>74</fpage>

          <lpage>77</lpage>

        </citation>

      </ref>


















      <ref id="1314974">

        <label>2</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Hughes, J.P., S. Rees, S.B. Kalindjian and K.L. Philpott,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2011</year>

          <article-title><![CDATA[Principles of early drug discovery.]]></article-title>

          <source>Br. J. Pharmacol.,</source>

          <volume>162</volume>

          <fpage>1239</fpage>

          <lpage>1249</lpage>

        </citation>

      </ref>


















      <ref id="1009048">

        <label>3</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Chin, Y.W., M.J. Balunas, H.B. Chai and A.D. Kinghorn,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2006</year>

          <article-title><![CDATA[Drug discovery from natural sources.]]></article-title>

          <source>AAPS J.,</source>

          <volume>8</volume>

          <fpage>E239</fpage>

          <lpage>E253</lpage>

        </citation>

      </ref>


















      <ref id="1764231">

        <label>4</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Zhang, M.Q. and B. Wilkinson,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2007</year>

          <article-title><![CDATA[Drug discovery beyond the 'rule-of-five'.]]></article-title>

          <source>Curr. Opin. Biotechnol.,</source>

          <volume>18</volume>

          <fpage>478</fpage>

          <lpage>488</lpage>

        </citation>

      </ref>


















      <ref id="633897">

        <label>5</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Cragg, G.M. and D.J. Newman,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2005</year>

          <article-title><![CDATA[Biodiversity: A continuing source of novel drug leads.]]></article-title>

          <source>Pure Appl. Chem.,</source>

          <volume>77</volume>

          <fpage>7</fpage>

          <lpage>24</lpage>

        </citation>

      </ref>


















      <ref id="1764232">

        <label>6</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Gupta, P. and K.H. Lee,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2007</year>

          <article-title><![CDATA[Genomics and proteomics in process development: opportunities and challenges.]]></article-title>

          <source>Trends Biotechnol.,</source>

          <volume>25</volume>

          <fpage>324</fpage>

          <lpage>330</lpage>

        </citation>

      </ref>


















      <ref id="1764234">

        <label>7</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Ahn, N.G. and A.H.J. Wang,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2008</year>

          <article-title><![CDATA[Proteomics and genomics: Perspectives on drug and target discovery.]]></article-title>

          <source>Curr. Opin. Chem. Biol.,</source>

          <volume>12</volume>

          <fpage>1</fpage>

          <lpage>3</lpage>

        </citation>

      </ref>


















      <ref id="1764237">

        <label>8</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Lee, J.A., M.T. Uhlik, C.M. Moxham, D. Tomandl and D.J. Sall,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2012</year>

          <article-title><![CDATA[Modern phenotypic drug discovery is a viable, neoclassic pharma strategy.]]></article-title>

          <source>J. Med. Chem.,</source>

          <volume>55</volume>

          <fpage>4527</fpage>

          <lpage>4538</lpage>

        </citation>

      </ref>


















      <ref id="1286465">

        <label>9</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Swinney, D.C. and J. Anthony,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2011</year>

          <article-title><![CDATA[How were new medicines discovered?]]></article-title>

          <source>Nat. Rev. Drug Discov.,</source>

          <volume>10</volume>

          <fpage>507</fpage>

          <lpage>519</lpage>

        </citation>

      </ref>


















      <ref id="1764239">

        <label>10</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Dolle, R.E.,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2001</year>

          <article-title><![CDATA[Comprehensive survey of combinatorial library synthesis: 2000.]]></article-title>

          <source>J. Comb. Chem.,</source>

          <volume>3</volume>

          <fpage>477</fpage>

          <lpage>517</lpage>

        </citation>

      </ref>


















      <ref id="1764241">

        <label>11</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Drews, J.,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2000</year>

          <article-title><![CDATA[Drug discovery: A historical perspective.]]></article-title>

          <source>Science,</source>

          <volume>287</volume>

          <fpage>1960</fpage>

          <lpage>1964</lpage>

        </citation>

      </ref>




















      <ref id="159546">

        <label>12</label>

        <citation citation-type="book" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Thomas, G.,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2011</year>

          <article-title><![CDATA[Medicinal Chemistry: An Introduction.]]></article-title>

          <source>Medicinal Chemistry: An Introduction.</source>

          <volume>2nd Edn.,</volume>

          <fpage>Pages: 646</fpage>

          <lpage>Pages: 646</lpage>

        </citation>

      </ref>
















      <ref id="529005">

        <label>13</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Newman, D.J., G.M. Cragg and K.M. Snader,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2000</year>

          <article-title><![CDATA[The influence of natural products upon drug discovery.]]></article-title>

          <source>Natl. Prod. Rep.,</source>

          <volume>17</volume>

          <fpage>215</fpage>

          <lpage>234</lpage>

        </citation>

      </ref>


















      <ref id="1764245">

        <label>14</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Lombardino, J.G. and J.A. Lowe,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2004</year>

          <article-title><![CDATA[The role of the medicinal chemist in drug discovery-then and now.]]></article-title>

          <source>Nat. Rev. Drug Discov.,</source>

          <volume>3</volume>

          <fpage>853</fpage>

          <lpage>862</lpage>

        </citation>

      </ref>


















      <ref id="1764247">

        <label>15</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Gershell, L.J. and J.H. Atkins,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2003</year>

          <article-title><![CDATA[A brief history of novel drug discovery technologies.]]></article-title>

          <source>Nat. Rev. Drug Discov.,</source>

          <volume>2</volume>

          <fpage>321</fpage>

          <lpage>327</lpage>

        </citation>

      </ref>




















      <ref id="159547">

        <label>16</label>

        <citation citation-type="book" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Kayser, O. and H. Warzecha,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2012</year>

          <article-title><![CDATA[Pharmaceutical Biotechnology: Drug Discovery and Clinical Applications.]]></article-title>

          <source>Pharmaceutical Biotechnology: Drug Discovery and Clinical Applications.</source>

          <volume> </volume>

          <fpage>Pages: 647</fpage>

          <lpage>Pages: 647</lpage>

        </citation>

      </ref>
















      <ref id="1764253">

        <label>17</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Dudzinski, D.M. and A.S. Kesselheim,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2008</year>

          <article-title><![CDATA[Scientific and legal viability of follow-on protein drugs.]]></article-title>

          <source>N. Engl. J. Med.,</source>

          <volume>358</volume>

          <fpage>843</fpage>

          <lpage>849</lpage>

        </citation>

      </ref>


















      <ref id="1764255">

        <label>18</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Tucker, J., S. Yakatan and S. Yakatan,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2008</year>

          <article-title><![CDATA[Biogenerics 2007: How far have we come?]]></article-title>

          <source>J. Commer. Biotechnol.,</source>

          <volume>14</volume>

          <fpage>56</fpage>

          <lpage>64</lpage>

        </citation>

      </ref>


















      <ref id="1764366">

        <label>19</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Qadir, M.I. and A. Abid,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2017</year>

          <article-title><![CDATA[Acute HIV infection: Advances in mechanisms and prophylactic therapeutic management.]]></article-title>

          <source>Crit. Rev. Eukaryotic Gene Express.,</source>

          <volume>27</volume>

          <fpage>79</fpage>

          <lpage>90</lpage>

        </citation>

      </ref>


















      <ref id="1764256">

        <label>20</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Triggle, D.J.,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2006</year>

          <article-title><![CDATA[Drug discovery and delivery in the 21st century.]]></article-title>

          <source>Med. Principles Pract.,</source>

          <volume>16</volume>

          <fpage>1</fpage>

          <lpage>14</lpage>

        </citation>

      </ref>






















      <ref id="61984">

        <label>21</label>

        <citation citation-type="book" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Pina, A.S., A. Hussain and A.C.A. Roque,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2010</year>

          <article-title><![CDATA[An Historical Overview of Drug Discovery.]]></article-title>

          <source>An Historical Overview of Drug Discovery.</source>

          <volume>2010</volume>

          <fpage>pp: 3-12</fpage>

          <lpage>pp: 3-12</lpage>

        </citation>

      </ref>














      <ref id="1764262">

        <label>22</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Yang, Y., S.J. Adelstein and A.I. Kassis,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2009</year>

          <article-title><![CDATA[Target discovery from data mining approaches.]]></article-title>

          <source>Drug Discov. Today,</source>

          <volume>14</volume>

          <fpage>147</fpage>

          <lpage>154</lpage>

        </citation>

      </ref>


















      <ref id="1764263">

        <label>23</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Bertram, L. and R.E. Tanzi,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2008</year>

          <article-title><![CDATA[Thirty years of Alzheimer's disease genetics: The implications of systematic meta-analyses.]]></article-title>

          <source>Nat. Rev. Neurosci.,</source>

          <volume>9</volume>

          <fpage>768</fpage>

          <lpage>778</lpage>

        </citation>

      </ref>


















      <ref id="1764265">

        <label>24</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Cox, J.J., F. Reimann, A.K. Nicholas, G. Thornton and E. Roberts <I>et al</I>.,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2006</year>

          <article-title><![CDATA[An <I>SCN9A</I> channelopathy causes congenital inability to experience pain.]]></article-title>

          <source>Nature,</source>

          <volume>444</volume>

          <fpage>894</fpage>

          <lpage>898</lpage>

        </citation>

      </ref>


















      <ref id="1764266">

        <label>25</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Yang, Y., Y. Wang, S. Li, Z. Xu and H. Li <I>et al</I>.,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2004</year>

          <article-title><![CDATA[Mutations in <I>SCN9A</I>, encoding a sodium channel alpha subunit, in patients with primary erythermalgia.]]></article-title>

          <source>J. Med. Genet.,</source>

          <volume>41</volume>

          <fpage>171</fpage>

          <lpage>174</lpage>

        </citation>

      </ref>


















      <ref id="1764267">

        <label>26</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Kurosawa, G., Y. Akahori, M. Morita, M. Sumitomo and N. Sato <I>et al</I>.,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2008</year>

          <article-title><![CDATA[Comprehensive screening for antigens overexpressed on carcinomas via isolation of human mAbs that may be therapeutic.]]></article-title>

          <source>Proc. Natl. Acad. Sci. USA.,</source>

          <volume>105</volume>

          <fpage>7287</fpage>

          <lpage>7292</lpage>

        </citation>

      </ref>


















      <ref id="1764291">

        <label>27</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Henning, S.W. and G. Beste,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2002</year>

          <article-title><![CDATA[Loss-of-function strategies in drug target validation.]]></article-title>

          <source>Curr. Drug Discov.,</source>

          <volume>5</volume>

          <fpage>17</fpage>

          <lpage>21</lpage>

        </citation>

      </ref>


















      <ref id="1764292">

        <label>28</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Honore, P., K. Kage, J. Mikusa, A.T. Watt and J.F. Johnston <I>et al</I>.,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2002</year>

          <article-title><![CDATA[Analgesic profile of intrathecal P2X<sub>3</sub> antisense oligonucleotide treatment in chronic inflammatory and neuropathic pain states in rats.]]></article-title>

          <source>Pain,</source>

          <volume>99</volume>

          <fpage>11</fpage>

          <lpage>19</lpage>

        </citation>

      </ref>


















      <ref id="1764293">

        <label>29</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Peet, N.P.,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2003</year>

          <article-title><![CDATA[What constitutes target validation?]]></article-title>

          <source>Targets,</source>

          <volume>2</volume>

          <fpage>125</fpage>

          <lpage>127</lpage>

        </citation>

      </ref>


















      <ref id="1764294">

        <label>30</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Chessell, I.P., J.P. Hatcher, C. Bountra, A.D. Michel and J.P. Hughes <I>et al</I>.,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2005</year>

          <article-title><![CDATA[Disruption of the P2X<sub>7</sub> purinoceptor gene abolishes chronic inflammatory and neuropathic pain.]]></article-title>

          <source>Pain,</source>

          <volume>114</volume>

          <fpage>386</fpage>

          <lpage>396</lpage>

        </citation>

      </ref>


















      <ref id="1764296">

        <label>31</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Abell, A.N., J.A. Rivera-Perez, B.D. Cuevas, M.T. Uhlik and S. Sather <i>et al</i>.,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2005</year>

          <article-title><![CDATA[Ablation of MEKK4 kinase activity causes neurulation and skeletal patterning defects in the mouse embryo.]]></article-title>

          <source>Mol. Cell. Biol.,</source>

          <volume>25</volume>

          <fpage>8948</fpage>

          <lpage>8959</lpage>

        </citation>

      </ref>


















      <ref id="996313">

        <label>32</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Castanotto, D. and J.J. Rossi,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2009</year>

          <article-title><![CDATA[The promises and pitfalls of RNA-interference-based therapeutics.]]></article-title>

          <source>Nature,</source>

          <volume>457</volume>

          <fpage>426</fpage>

          <lpage>433</lpage>

        </citation>

      </ref>


















      <ref id="1764297">

        <label>33</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Whitehead, K.A., R. Langer and D.G. Anderson,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2009</year>

          <article-title><![CDATA[Knocking down barriers: Advances in siRNA delivery.]]></article-title>

          <source>Nat. Rev. Drug Discov.,</source>

          <volume>8</volume>

          <fpage>129</fpage>

          <lpage>138</lpage>

        </citation>

      </ref>


















      <ref id="1764298">

        <label>34</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Ugolini, G., S. Marinelli, S. Covaceuszach, A. Cattaneo and F. Pavone,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2007</year>

          <article-title><![CDATA[The function neutralizing anti-TrkA antibody MNAC13 reduces inflammatory and neuropathic pain.]]></article-title>

          <source>Proc. Natl. Acad. Sci. USA.,</source>

          <volume>104</volume>

          <fpage>2985</fpage>

          <lpage>2990</lpage>

        </citation>

      </ref>


















      <ref id="1764300">

        <label>35</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Zanders, E.D., D.S. Bailey and P.M. Dean,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2002</year>

          <article-title><![CDATA[Probes for chemical genomics by design.]]></article-title>

          <source>Drug Discov. Today,</source>

          <volume>7</volume>

          <fpage>711</fpage>

          <lpage>718</lpage>

        </citation>

      </ref>


















      <ref id="1764302">

        <label>36</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Fox, S., S. Farr-Jones, L. Sopchak, A. Boggs, H.W. Nicely, R. Khoury and M. Biros,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2006</year>

          <article-title><![CDATA[High-throughput screening: update on practices and success.]]></article-title>

          <source>J. Biomol. Screening,</source>

          <volume>11</volume>

          <fpage>864</fpage>

          <lpage>869</lpage>

        </citation>

      </ref>


















      <ref id="1764303">

        <label>37</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Boppana, K., P.K. Dubey, S.A.R.P. Jagarlapudi, S. Vadivelan and G. Rambabu,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2009</year>

          <article-title><![CDATA[Knowledge based identification of MAO-B selective inhibitors using pharmacophore and structure based virtual screening models.]]></article-title>

          <source>Eur. J. Med. Chem.,</source>

          <volume>44</volume>

          <fpage>3584</fpage>

          <lpage>3590</lpage>

        </citation>

      </ref>


















      <ref id="1764305">

        <label>38</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>McInnes, C.,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2007</year>

          <article-title><![CDATA[Virtual screening strategies in drug discovery.]]></article-title>

          <source>Curr. Opin. Chem. Biol.,</source>

          <volume>11</volume>

          <fpage>494</fpage>

          <lpage>502</lpage>

        </citation>

      </ref>


















      <ref id="1764307">

        <label>39</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Frearson, J.A. and I.T. Collie,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2009</year>

          <article-title><![CDATA[HTS and hit finding in academia-from chemical genomics to drug discovery.]]></article-title>

          <source>Drug Discov. Today,</source>

          <volume>14</volume>

          <fpage>1150</fpage>

          <lpage>1158</lpage>

        </citation>

      </ref>






















      <ref id="61985">

        <label>40</label>

        <citation citation-type="book" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Dunne, A., M. Jowett and S. Rees,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2009</year>

          <article-title><![CDATA[Use of Primary Human Cells in High-Throughput Screens.]]></article-title>

          <source>Use of Primary Human Cells in High-Throughput Screens.</source>

          <volume>2009</volume>

          <fpage>pp: 239-257</fpage>

          <lpage>pp: 239-257</lpage>

        </citation>

      </ref>














      <ref id="1764308">

        <label>41</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Hughes, B.,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2010</year>

          <article-title><![CDATA[2009 FDA drug approvals.]]></article-title>

          <source>Nat. Rev. Drug Discov.,</source>

          <volume>9</volume>

          <fpage>89</fpage>

          <lpage>92</lpage>

        </citation>

      </ref>


















      <ref id="1764309">

        <label>42</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Drake, J.M. and B.D. Griffen,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2010</year>

          <article-title><![CDATA[Early warning signals of extinction in deteriorating environments.]]></article-title>

          <source>Nature,</source>

          <volume>467</volume>

          <fpage>456</fpage>

          <lpage>459</lpage>

        </citation>

      </ref>


















      <ref id="1764310">

        <label>43</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Maqbool, F., S. Mostafalou, H. Bahadar and M. Abdollahi,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2016</year>

          <article-title><![CDATA[Review of endocrine disorders associated with environmental toxicants and possible involved mechanisms.]]></article-title>

          <source>Life Sci.,</source>

          <volume>145</volume>

          <fpage>265</fpage>

          <lpage>273</lpage>

        </citation>

      </ref>


















      <ref id="1764312">

        <label>44</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Eichler, H.G., B. Aronsson, E. Abadie and T. Salmonson,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2010</year>

          <article-title><![CDATA[New drug approval success rate in Europe in 2009.]]></article-title>

          <source>Nat. Rev. Drug Discov.,</source>

          <volume>9</volume>

          <fpage>355</fpage>

          <lpage>356</lpage>

        </citation>

      </ref>


















      <ref id="1764313">

        <label>45</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Mullard, A.,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2016</year>

          <article-title><![CDATA[2015 FDA drug approvals.]]></article-title>

          <source>Nat. Rev. Drug Discov.,</source>

          <volume>15</volume>

          <fpage>73</fpage>

          <lpage>76</lpage>

        </citation>

      </ref>


















      <ref id="1764314">

        <label>46</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Brown, M.J.,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2009</year>

          <article-title><![CDATA[The impact of clinical trials legislation on clinical pharmacology: Problems and solutions.]]></article-title>

          <source>Br. J. Clin. Pharmacol.,</source>

          <volume>67</volume>

          <fpage>487</fpage>

          <lpage>493</lpage>

        </citation>

      </ref>


















      <ref id="1764316">

        <label>47</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Sherman, R.E., J. Li, S. Shapley, M. Robb and J. Woodcock,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2013</year>

          <article-title><![CDATA[Expediting drug development-the FDA's new &#147;breakthrough therapy&#148; designation.]]></article-title>

          <source>N. Engl. J. Med.,</source>

          <volume>369</volume>

          <fpage>1877</fpage>

          <lpage>1880</lpage>

        </citation>

      </ref>


















      <ref id="1764317">

        <label>48</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Michelini, E., L. Cevenini, L. Mezzanotte, A. Coppa and A. Roda,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2010</year>

          <article-title><![CDATA[Cell-based assays: Fuelling drug discovery.]]></article-title>

          <source>Anal. Bioanal. Chem.,</source>

          <volume>398</volume>

          <fpage>227</fpage>

          <lpage>238</lpage>

        </citation>

      </ref>


















      <ref id="1764319">

        <label>49</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Moore, K. and S. Rees,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2001</year>

          <article-title><![CDATA[Cell-based versus isolated target screening: How lucky do you feel?]]></article-title>

          <source>J. Biomol. Screening,</source>

          <volume>6</volume>

          <fpage>69</fpage>

          <lpage>74</lpage>

        </citation>

      </ref>


















      <ref id="1258731">

        <label>50</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Zhang, J.H., T.D.Y. Chung and K.R. Oldenburg,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>1999</year>

          <article-title><![CDATA[A simple statistical parameter for use in evaluation and validation of high throughput screening assays.]]></article-title>

          <source>J. Biomol. Screen.,</source>

          <volume>4</volume>

          <fpage>67</fpage>

          <lpage>73</lpage>

        </citation>

      </ref>


















      <ref id="1764320">

        <label>51</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Stables, J., L.C. Mattheakis, R. Chang and S. Rees,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2000</year>

          <article-title><![CDATA[Recombinant aequorin as reporter of changes in intracellular calcium in mammalian cells.]]></article-title>

          <source>Methods Enzymol.,</source>

          <volume>327</volume>

          <fpage>456</fpage>

          <lpage>471</lpage>

        </citation>

      </ref>


















      <ref id="1764321">

        <label>52</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Schmidt, B.J., J.A. Papin and C.J. Musante,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2013</year>

          <article-title><![CDATA[Mechanistic systems modeling to guide drug discovery and development.]]></article-title>

          <source>Drug Discov. Today,</source>

          <volume>18</volume>

          <fpage>116</fpage>

          <lpage>127</lpage>

        </citation>

      </ref>


















      <ref id="1764322">

        <label>53</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Maqbool, F., M. Safavi, H. Bahadar, M. Rahimifard, K. Niaz and M. Abdollahi,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2015</year>

          <article-title><![CDATA[Discovery approaches for novel dyslipidemia drugs.]]></article-title>

          <source>Curr. Drug Discov. Technol.,</source>

          <volume>12</volume>

          <fpage>90</fpage>

          <lpage>116</lpage>

        </citation>

      </ref>


















      <ref id="1764324">

        <label>54</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Mai, A.,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2014</year>

          <article-title><![CDATA[Targeting epigenetics in drug discovery.]]></article-title>

          <source>ChemMedChem,</source>

          <volume>9</volume>

          <fpage>415</fpage>

          <lpage>417</lpage>

        </citation>

      </ref>


















      <ref id="1764325">

        <label>55</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Burkhard, J.A., G. Wuitschik, M. Rogers-Evans, K. Muller and E.M. Carreira,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2010</year>

          <article-title><![CDATA[Oxetanes as versatile elements in drug discovery and synthesis.]]></article-title>

          <source>Angewandte Chemie Int. Edn.,</source>

          <volume>49</volume>

          <fpage>9052</fpage>

          <lpage>9067</lpage>

        </citation>

      </ref>


















      <ref id="1764326">

        <label>56</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Dai, H.X., A.F. Stepan, M.S. Plummer, Y.H. Zhang and J.Q. Yu,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2011</year>

          <article-title><![CDATA[Divergent C-H functionalizations directed by sulfonamide pharmacophores: Late-stage diversification as a tool for drug discovery.]]></article-title>

          <source>J. Am. Chem. Soc.,</source>

          <volume>133</volume>

          <fpage>7222</fpage>

          <lpage>7228</lpage>

        </citation>

      </ref>


















      <ref id="1764328">

        <label>57</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Leach, A.G., H.D. Jones, D.A. Cosgrove, P.W. Kenny and L. Ruston <i>et al</i>.,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2006</year>

          <article-title><![CDATA[Matched molecular pairs as a guide in the optimization of pharmaceutical properties; a study of aqueous solubility, plasma protein binding and oral exposure.]]></article-title>

          <source>J. Med. Chem.,</source>

          <volume>49</volume>

          <fpage>6672</fpage>

          <lpage>6682</lpage>

        </citation>

      </ref>


















      <ref id="1764329">

        <label>58</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Keefer, C.E., G. Chang and G.W. Kauffman,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2011</year>

          <article-title><![CDATA[Extraction of tacit knowledge from large ADME data sets via pairwise analysis.]]></article-title>

          <source>Bioorg. Med. Chem.,</source>

          <volume>19</volume>

          <fpage>3739</fpage>

          <lpage>3749</lpage>

        </citation>

      </ref>


















      <ref id="1429786">

        <label>59</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Friesner, R.A., R.B. Murphy, M.P. Repasky, L.L. Frye and J.R. Greenwood <i>et al</i>.,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2006</year>

          <article-title><![CDATA[Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes.]]></article-title>

          <source>J. Med. Chem.,</source>

          <volume>49</volume>

          <fpage>6177</fpage>

          <lpage>6196</lpage>

        </citation>

      </ref>


















      <ref id="1764330">

        <label>60</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Newman, D.J. and G.M. Cragg,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2012</year>

          <article-title><![CDATA[Natural products as sources of new drugs over the 30 years from 1981 to 2010.]]></article-title>

          <source>J. Nat. Prod.,</source>

          <volume>75</volume>

          <fpage>311</fpage>

          <lpage>335</lpage>

        </citation>

      </ref>


















      <ref id="1764331">

        <label>61</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Bauer, A. and M. Bronstrup,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2014</year>

          <article-title><![CDATA[Industrial natural product chemistry for drug discovery and development.]]></article-title>

          <source>Nat. Prod. Rep.,</source>

          <volume>31</volume>

          <fpage>35</fpage>

          <lpage>60</lpage>

        </citation>

      </ref>


















      <ref id="1764333">

        <label>62</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Ritchie, T.J. and S.J.F. Macdonald,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2009</year>

          <article-title><![CDATA[The impact of aromatic ring count on compound developability-are too many aromatic rings a liability in drug design?]]></article-title>

          <source>Drug Discov. Today,</source>

          <volume>14</volume>

          <fpage>1011</fpage>

          <lpage>1020</lpage>

        </citation>

      </ref>


















      <ref id="1764338">

        <label>63</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Lovering, F., J. Bikker and C. Humblet,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2009</year>

          <article-title><![CDATA[Escape from flatland: Increasing saturation as an approach to improving clinical success.]]></article-title>

          <source>J. Med. Chem.,</source>

          <volume>52</volume>

          <fpage>6752</fpage>

          <lpage>6756</lpage>

        </citation>

      </ref>




















      <ref id="159549">

        <label>64</label>

        <citation citation-type="book" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Nicolaou, K.C. and T. Montagnon,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2008</year>

          <article-title><![CDATA[Molecules that Changed the World.]]></article-title>

          <source>Molecules that Changed the World.</source>

          <volume> </volume>

          <fpage>Pages: 385</fpage>

          <lpage>Pages: 385</lpage>

        </citation>

      </ref>
















      <ref id="1764341">

        <label>65</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Stepan, A.F., G.W. Kauffman, C.E. Keefer, P.R. Verhoest and M. Edwards,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2013</year>

          <article-title><![CDATA[Evaluating the differences in cycloalkyl ether metabolism using the design parameter &#147;lipophilic metabolism efficiency&#148; (LipMetE) and a matched molecular pairs analysis.]]></article-title>

          <source>J. Med. Chem.,</source>

          <volume>56</volume>

          <fpage>6985</fpage>

          <lpage>6990</lpage>

        </citation>

      </ref>


















      <ref id="1764342">

        <label>66</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Stepan, A.F., K. Karki, W.S. McDonald, P.H. Dorff and J.K. Dutra <I>et al</I>.,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2011</year>

          <article-title><![CDATA[Metabolism-directed design of oxetane-containing arylsulfonamide derivatives as γ-secretase inhibitors.]]></article-title>

          <source>J. Med. Chem.,</source>

          <volume>54</volume>

          <fpage>7772</fpage>

          <lpage>7783</lpage>

        </citation>

      </ref>


















      <ref id="1764344">

        <label>67</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Muller, K., C. Faeh and F. Diederich,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2007</year>

          <article-title><![CDATA[Fluorine in pharmaceuticals: Looking beyond intuition.]]></article-title>

          <source>Science,</source>

          <volume>317</volume>

          <fpage>1881</fpage>

          <lpage>1886</lpage>

        </citation>

      </ref>


















      <ref id="1764347">

        <label>68</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Hernandes, M.Z., S.M.T. Cavalcanti, D.R.M. Moreira, W.F. de Azevedo Jr. and A.C.L. Leite,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2010</year>

          <article-title><![CDATA[Halogen atoms in the modern medicinal chemistry: Hints for the drug design.]]></article-title>

          <source>Curr. Drug Targets,</source>

          <volume>11</volume>

          <fpage>303</fpage>

          <lpage>314</lpage>

        </citation>

      </ref>


















      <ref id="1764350">

        <label>69</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Schreiber, S.L.,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2011</year>

          <article-title><![CDATA[Organic synthesis toward small-molecule probes and drugs.]]></article-title>

          <source>Proc. Natl. Acad. Sci. USA.,</source>

          <volume>108</volume>

          <fpage>6699</fpage>

          <lpage>6702</lpage>

        </citation>

      </ref>


















      <ref id="1764354">

        <label>70</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Nicolaou, K.C., C.R. Hale, C. Nilewski and H.A. Ioannidou,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2012</year>

          <article-title><![CDATA[Constructing molecular complexity and diversity: Total synthesis of natural products of biological and medicinal importance.]]></article-title>

          <source>Chem. Soc. Rev.,</source>

          <volume>41</volume>

          <fpage>5185</fpage>

          <lpage>5238</lpage>

        </citation>

      </ref>


















      <ref id="1764355">

        <label>71</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Sellers, W.R.,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2011</year>

          <article-title><![CDATA[A blueprint for advancing genetics-based cancer therapy.]]></article-title>

          <source>Cell,</source>

          <volume>147</volume>

          <fpage>26</fpage>

          <lpage>31</lpage>

        </citation>

      </ref>


















      <ref id="1764357">

        <label>72</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Nicolaou, K.C.,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2014</year>

          <article-title><![CDATA[Advancing the drug discovery and development process.]]></article-title>

          <source>Angewandte Chemie Int. Edn.,</source>

          <volume>53</volume>

          <fpage>9128</fpage>

          <lpage>9140</lpage>

        </citation>

      </ref>


















      <ref id="1764359">

        <label>73</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Williams, S.A., W.C. Anderson, M.T. Santaguida and S.J. Dylla,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2013</year>

          <article-title><![CDATA[Patient-derived xenografts, the cancer stem cell paradigm and cancer pathobiology in the 21st century.]]></article-title>

          <source>Lab. Invest.,</source>

          <volume>93</volume>

          <fpage>970</fpage>

          <lpage>982</lpage>

        </citation>

      </ref>


















      <ref id="1764361">

        <label>74</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>De Palma, M. and D. Hanahan,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2012</year>

          <article-title><![CDATA[The biology of personalized cancer medicine: Facing individual complexities underlying hallmark capabilities.]]></article-title>

          <source>Mol. Oncol.,</source>

          <volume>6</volume>

          <fpage>111</fpage>

          <lpage>127</lpage>

        </citation>

      </ref>


















      <ref id="1764363">

        <label>75</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Slusher, B.S., P.J. Conn, S. Frye, M. Glicksman and M. Arkin,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2013</year>

          <article-title><![CDATA[Bringing together the academic drug discovery community.]]></article-title>

          <source>Nat. Rev. Drug Discov.,</source>

          <volume>12</volume>

          <fpage>811</fpage>

          <lpage>812</lpage>

        </citation>

      </ref>


















      <ref id="1764364">

        <label>76</label>

        <citation citation-type="journal" xlink:type="simple">

          <person-group person-group-type="author">

            <name name-style="western">

              <surname>Paul, S.M., D.S. Mytelka, C.T. Dunwiddie, C.C. Persinger, B.H. Munos, S.R. Lindborg and A.L. Schacht,</surname>

              <given-names></given-names>

            </name>

          </person-group>

          <year>2010</year>

          <article-title><![CDATA[How to improve R&D productivity: The pharmaceutical industry's grand challenge.]]></article-title>

          <source>Nat. Rev. Drug Discov.,</source>

          <volume>9</volume>

          <fpage>203</fpage>

          <lpage>214</lpage>

        </citation>

      </ref>
















  </ref-list>

</article>

